Prenetics Global is trading at $21.47, up 5.98%, in pre-market; the reason for the October 16 gain remains unclear.

  • No verified company-specific announcement explaining the October 16 pre-market move has surfaced; the IM8-NBA partnership was announced October 12.
  • Lucid Capital Markets’ Buy initiation and $54 target were also reported October 12, so they do not establish a fresh catalyst. Major U.S. indices are mixed, with only modest moves, offering no clear broad-market explanation.